FREE SHIPPING ON ORDERS OVER £60 (UK)

The avant -garde of biotechnological innovation in products based on 100% pure fungi

In Hifas da Terra we bet on the Innovation and scientific research offering premium quality supplements and performing preclinical and clinical trials In addition to other scientific studies.

In this way we transfer the border of the Biotech and we opened the way in the Biopharma, investigating new patentable product status and new Medical Device.

Key data on R&D

We allocate the 62% From our benefits to R&D

More than 200 Experts work with us. We collaborate with various medical and scientific entities.

We have a wide scientific team and more than 200 multidisciplinary collaborators. Some of the entities we collaborate are:

More than 15 active projects

We are the Biotech Leader in Research and Development of Innovative Supplements, with more than15 active studieswhich include clinical trials highly innovative linked to projects Micromarker and Microimmunomama. Likewise, other studies of great interest in other fundamental areas stand out.

Scientific and Biotechnological Innovation

Through innovation we propose new processes and responsible protocols that positively impact people ...

We innovate in the ecological cultivation of fungi by introducing sustainable production in bioreactors, a pioneering system that allows mycelium to grow in standardized conditions and that expands the medical applications of the extracts by varying culture means, selecting specific strains oriented to results, etc. This system also allows us to isolate most effectively active biomolecules and new ingredients for our nutritional supplements.

We are laying the foundations for what we call ‘à la carte formulas’, i.e. the formulation of innovative products to address specific situations and conditions. At Hifas da Terra, we are currently conducting studies on our products and on the optimisation of the production process.

The acquired know-how thanks to the scientific and technological knowledge of our R&D team opens the doors to the creation of new patents that are based on fungi, either in the form of food complement or Medical Device, among others.

Accordion content ...

Micromarker

Micromarker

2021 – 2024
  • Home 2021
  • Clinical essay in colorectal cancer
  • Patients: 144
  • Medical Center: Galicia Sur Biomedical Foundation
Microimmunomama

Microimmunomama

2021 – 2024
  • Home 2021
  • Clinical test in breast cancer
  • Patients: +100
  • Medical Center: Álvaro Cunqueiro Hospital
AI-VIDDA

AI-VIDDA

RIS3 2021–2027
  • AI and biotechnology in older people to increase years of healthy life.
New disruptive ingredients

New disruptive ingredients

Belong 2023–2025
  • Sustainable alternatives in the agri -food sector (AcceleREat - Agrifood belong).
Nutrigen 4.0

Nutrigen 4.0

2021 – 2024
  • Intelligent processes with galic gay fungi.
Covid-19 study in residences

Covid-19 study in residences

2020
  • Observational study with COVID-19 patients and fungal extracts.
  • Patients: 76
  • Medical Center: Leganés / Dr. Soler
Mico-Artro

Mico-Artro

2018
  • Relief of osteoarthritis symptoms with fungi.
  • Patients: 20
  • Medical Center: OAFI / Dr. Moller
Neurofood

Neurofood

2018 – 2021
  • Human essay on fungi effects in memory and cognition.
  • Patients: 40
  • Medical Center: Foltra / Dr. Devesa Center
FungitechOnco

FungitechOnco

2019 – 2021
  • Medicinal fungi for gastric and colorectal cancer prevention.
Dismetasín

Dismetasín

2018 – 2021
  • Mico-Mix and Metabolic Syndrome. Santiago Hospital / Dr. Casanueva.
  • Patients: 44